Litigation Details for In re Lantus Direct Purchaser Antitrust Litigation (D. Mass. 2016)

In re Lantus Direct Purchaser Antitrust Litigation (D. Mass. 2016)

Docket		Date Filed	2016-12-29
Court	District Court, D. Massachusetts	Date Terminated	2018-10-24
Cause	15:1 Antitrust Litigation	Assigned To	Judith G. Dein
Jury Demand	Both	Referred To
Patents	8,556,864; 9,526,844
Link to Docket	External link to docket

Biologic Drugs cited in In re Lantus Direct Purchaser Antitrust Litigation

Details for In re Lantus Direct Purchaser Antitrust Litigation (D. Mass. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-12-21	175	Order on Motion to Dismiss/Lack of Jurisdiction	improperly listed one of these patents, United States Patent No. 8,556,864, which was issued on October … Its original patent for insulin glargine, U.S. Patent No. 5,656,722 (the “’722 Patent”), as extended…infringed on one of Sanofi’s patents, U.S. Patent No. 9,526,844 (the “‘844 Patent”), and that Mylan had proved… improperly listing patents in the FDA’s Orange Book and filing meritless patent infringement actions…application the patent number and the expiration date of any patent which claims the	External link to document